Andrew B Forbes1, Muhammad Akram2, David Pilcher3, Jamie Cooper4, Rinaldo Bellomo4. 1. School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia Andrew.Forbes@monash.edu. 2. School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. 3. Centre for Outcome and Resource Evaluation (CORE), Australian and New Zealand Intensive Care Society (ANZICS), Carlton, VIC, Australia Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, VIC, Australia. 4. Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, VIC, Australia.
Abstract
BACKGROUND: Cluster randomised crossover trials have been utilised in recent years in the health and social sciences. Methods for analysis have been proposed; however, for binary outcomes, these have received little assessment of their appropriateness. In addition, methods for determination of sample size are currently limited to balanced cluster sizes both between clusters and between periods within clusters. This article aims to extend this work to unbalanced situations and to evaluate the properties of a variety of methods for analysis of binary data, with a particular focus on the setting of potential trials of near-universal interventions in intensive care to reduce in-hospital mortality. METHODS: We derive a formula for sample size estimation for unbalanced cluster sizes, and apply it to the intensive care setting to demonstrate the utility of the cluster crossover design. We conduct a numerical simulation of the design in the intensive care setting and for more general configurations, and we assess the performance of three cluster summary estimators and an individual-data estimator based on binomial-identity-link regression. RESULTS: For settings similar to the intensive care scenario involving large cluster sizes and small intra-cluster correlations, the sample size formulae developed and analysis methods investigated are found to be appropriate, with the unweighted cluster summary method performing well relative to the more optimal but more complex inverse-variance weighted method. More generally, we find that the unweighted and cluster-size-weighted summary methods perform well, with the relative efficiency of each largely determined systematically from the study design parameters. Performance of individual-data regression is adequate with small cluster sizes but becomes inefficient for large, unbalanced cluster sizes. When outcome prevalences are 6% or less and the within-cluster-within-period correlation is 0.05 or larger, all methods display sub-nominal confidence interval coverage, with the less prevalent the outcome the worse the coverage. LIMITATIONS: As with all simulation studies, conclusions are limited to the configurations studied. We confined attention to detecting intervention effects on an absolute risk scale using marginal models and did not explore properties of binary random effects models. CONCLUSION: Cluster crossover designs with binary outcomes can be analysed using simple cluster summary methods, and sample size in unbalanced cluster size settings can be determined using relatively straightforward formulae. However, caution needs to be applied in situations with low prevalence outcomes and moderate to high intra-cluster correlations.
BACKGROUND: Cluster randomised crossover trials have been utilised in recent years in the health and social sciences. Methods for analysis have been proposed; however, for binary outcomes, these have received little assessment of their appropriateness. In addition, methods for determination of sample size are currently limited to balanced cluster sizes both between clusters and between periods within clusters. This article aims to extend this work to unbalanced situations and to evaluate the properties of a variety of methods for analysis of binary data, with a particular focus on the setting of potential trials of near-universal interventions in intensive care to reduce in-hospital mortality. METHODS: We derive a formula for sample size estimation for unbalanced cluster sizes, and apply it to the intensive care setting to demonstrate the utility of the cluster crossover design. We conduct a numerical simulation of the design in the intensive care setting and for more general configurations, and we assess the performance of three cluster summary estimators and an individual-data estimator based on binomial-identity-link regression. RESULTS: For settings similar to the intensive care scenario involving large cluster sizes and small intra-cluster correlations, the sample size formulae developed and analysis methods investigated are found to be appropriate, with the unweighted cluster summary method performing well relative to the more optimal but more complex inverse-variance weighted method. More generally, we find that the unweighted and cluster-size-weighted summary methods perform well, with the relative efficiency of each largely determined systematically from the study design parameters. Performance of individual-data regression is adequate with small cluster sizes but becomes inefficient for large, unbalanced cluster sizes. When outcome prevalences are 6% or less and the within-cluster-within-period correlation is 0.05 or larger, all methods display sub-nominal confidence interval coverage, with the less prevalent the outcome the worse the coverage. LIMITATIONS: As with all simulation studies, conclusions are limited to the configurations studied. We confined attention to detecting intervention effects on an absolute risk scale using marginal models and did not explore properties of binary random effects models. CONCLUSION: Cluster crossover designs with binary outcomes can be analysed using simple cluster summary methods, and sample size in unbalanced cluster size settings can be determined using relatively straightforward formulae. However, caution needs to be applied in situations with low prevalence outcomes and moderate to high intra-cluster correlations.
Authors: Verinder S Sidhu; Thu-Lan Kelly; Nicole Pratt; Stephen E Graves; Rachelle Buchbinder; Sam Adie; Kara Cashman; Ilana Ackerman; Durga Bastiras; Roger Brighton; Alexander W R Burns; Beng Hock Chong; Ornella Clavisi; Maggie Cripps; Mark Dekkers; Richard de Steiger; Michael Dixon; Andrew Ellis; Elizabeth C Griffith; David Hale; Amber Hansen; Anthony Harris; Raphael Hau; Mark Horsley; Dugal James; Omar Khorshid; Leonard Kuo; Peter Lewis; David Lieu; Michelle Lorimer; Samuel MacDessi; Peter McCombe; Catherine McDougall; Jonathan Mulford; Justine Maree Naylor; Richard S Page; John Radovanovic; Michael Solomon; Rami Sorial; Peter Summersell; Phong Tran; William L Walter; Steve Webb; Chris Wilson; David Wysocki; Ian A Harris Journal: JAMA Date: 2022-08-23 Impact factor: 157.335
Authors: Paul J Young; Sean M Bagshaw; Andrew B Forbes; Alistair D Nichol; Stephen E Wright; Michael Bailey; Rinaldo Bellomo; Richard Beasley; Kathy Brickell; Glenn M Eastwood; David J Gattas; Frank van Haren; Edward Litton; Diane M Mackle; Colin J McArthur; Shay P McGuinness; Paul R Mouncey; Leanlove Navarra; Dawn Opgenorth; David Pilcher; Manoj K Saxena; Steve A Webb; Daisy Wiley; Kathryn M Rowan Journal: JAMA Date: 2020-02-18 Impact factor: 56.272
Authors: Verinder Singh Sidhu; Steven E Graves; Rachelle Buchbinder; Justine Maree Naylor; Nicole L Pratt; Richard S de Steiger; Beng H Chong; Ilana N Ackerman; Sam Adie; Anthony Harris; Amber Hansen; Maggie Cripps; Michelle Lorimer; Steve Webb; Ornella Clavisi; Elizabeth C Griffith; Durga Anandan; Grace O'Donohue; Thu-Lan Kelly; Ian A Harris Journal: BMJ Open Date: 2019-11-06 Impact factor: 2.692
Authors: Charlotte L Zwager; Pieter Roel Tuinman; Harm-Jan de Grooth; Jos Kooter; Hans Ket; Lucas M Fleuren; Paul W G Elbers Journal: Crit Care Date: 2019-11-21 Impact factor: 9.097